The Gross Margin of Mayinglong Pharmaceutical Group Co Ltd (600993.SS) is 46.43%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 46.43% |
| 2022-12-31 | 42.30% |
| 2021-12-31 | 40.36% |
| 2020-12-31 | 40.42% |
| 2019-12-31 | 40.95% |
| 2018-12-31 | 45.09% |
| 2017-12-31 | 50.06% |
| 2016-12-31 | 36.11% |
| 2015-12-31 | 39.41% |
| 2014-12-31 | 41.76% |